Ocular Regenerative Medicine – Translational Medicine: From bench to bedside

My Session Status

When:

10:45 AM, Friday 1 Jun 2018 (1 hour 30 minutes)

Breaks:

Lunch 12:15 PM to 01:30 PM (1 hour 15 minutes)

Where:

Metro Toronto Convention Centre (South Building) - Room 803

Theme:

Ocular Regenerative Medicine

LEARNING OBJECTIVES
At the end of this session, participants will be able to:

Assess the need for a limbal stem cell ex vivo expansion program in North America
Describe a novel surgical procedure for dealing with recalcitrant pterygiums
Illustrate how neurotinization surgery can be used to treat patients suffering from anaesthetic corneas

CANMEDS ROLES: Health Advocate, Medical Expert

Dr. Allan Slomovic, MSc, MD, FRCSC

Moderator

Victor L. Perez MD

Participant

Dr. Soosan Jacob, MS, FRCS, DNB, MNAMS

Participant

Dr. Isabelle Brunette, MD, FRCSC

Moderator

Sub Sessions

Why we need a limbal stem cell ex vivo expansion program

10:45 AM - 11:00 AM | 15 minutes

Keynote Speaker

Victor L. Perez MD

Participant

Q & A

11:00 AM - 11:05 AM | 5 minutes

Young donor PDEK for clearing corneal stromal opacity: Do stem cells play a role?

11:05 AM - 11:15 AM | 10 minutes

Keynote Speaker

Dr. Soosan Jacob, MS, FRCS, DNB, MNAMS

Participant

Q & A

11:15 AM - 11:18 AM | 3 minutes

Simple Limbal Epithelial Transplantation (S.L.E.T.) for recurrent double-headed pterygium

11:18 AM - 11:28 AM | 10 minutes

Authors: Tanguy Boutin, Zale Mednick, Allan Slomovic Author Disclosure Block: T. boutin: None. Z. Mednick: None. A. Slomovic: Employment/honoraria/consulting fees; Name of Commercial Company(s); Alcon Canada, Bausch and Lomb Canada. Membership on an advisory panel, standing committee or board of directors; Name of Commercial Company(s); Allergan, Santen, Shire Canada, AMO. Abstract Body: Purpose: To show a novel surgical procedure to tre...